Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Bausch Health Companies Inc's Business Segments

Bausch Health Companies Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
5
Per the company's own filing, this quarter
Largest Segment
Bausch + Lomb
49.3% of revenue
Total Revenue
$ 2,524
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BHC/segments
https://api.csimarket.com/api/v1/companies/BHC/geographic
https://api.csimarket.com/api/v1/companies/BHC/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

49%largest
  • Bausch + Lomb49.3%
  • Salix25.3%
  • International Rx11.3%
  • Diversified7.3%
  • Solta Medical6.8%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Bausch + LombQ1 FY2026$ 1,24449.3%$ 277
SalixQ1 FY2026$ 63925.3%$ 468
International RxQ1 FY2026$ 28511.3%$ 88
2 more segments available

Sign in to unlock the full Bausch Health Companies Inc dataset.

Revenue by Product & Service Category - Q1 FY2026

99%largest
  • Product99%
  • Product and Service, Other1%
  • Price Appreciation Credit0.1%

Revenue by Product & Service Category - Q1 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
ProductQ1 FY2026$ 2,50099%
Product and Service, OtherQ1 FY2026$ 241%
Price Appreciation CreditQ1 FY2026$ 20.1%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

Description of Bausch Health Companies Inc

Bausch Health Companies Inc. (formerly known as Valeant Pharmaceuticals International Inc.) is a multinational pharmaceutical company that was founded in 1960 and is based in Laval, Canada. The company focuses on innovative pharmaceutical products and medical devices for the treatment of eye health, gastroenterology, dermatology, and aesthetics. Bausch Health operates in more than 100 countries, selling products to healthcare providers and patients around the world.

Bausch Health has a diverse portfolio of products, including prescription drugs, over-the-counter medications, contact lenses, surgical instruments, and biologic drugs. The company has a number of strong brands, including Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. Bausch + Lomb is a leading global eye health business that offers contact lenses, ocular drugs, and surgical instruments. Salix Pharmaceuticals is a specialized gastroenterology company that offers treatments for gastrointestinal diseases. Ortho Dermatologics offers prescription dermatology products.

Bausch Health is committed to research and development, spending significant resources on developing new products and improving existing ones. The company has a strong pipeline of products, and it invests heavily in clinical trials to ensure that its products are effective and safe.

Bausch Health has faced regulatory and legal challenges in the past, including allegations of accounting fraud and price gouging for some of its drugs. In response, the company has implemented a number of reforms, including changes to its governance structure and pricing policies.

Overall, Bausch Health Companies Inc. is a major player in the pharmaceutical industry, with a diverse portfolio of products and a strong commitment to research and development. The company has faced challenges in the past but has taken steps to improve its reputation and ensure that its products are accessible and affordable for patients.
Bausch Health Companies Inc, formerly known as Valeant Pharmaceuticals International Inc, is a prominent multinational pharmaceutical and healthcare company that operates across multiple segments. The company is dedicated to improving patients lives through innovative products and services and has established a diversified portfolio that spans several therapeutic areas. Below is an extensive overview of the segments, products, and services that Bausch Health Companies Inc offers:

1. Eye Health
Bausch Health is recognized as a global leader in eye health, providing a comprehensive range of products tailored to meet the needs of vision caregivers and patients alike. Its offerings include:

- Prescription Medicines: These encompass treatments for various eye conditions, such as glaucoma, dry eye, and ocular inflammation. A notable product is Vyzulta, an ophthalmic solution designed to lower intraocular pressure in patients with glaucoma.

- Over-the-Counter Products: These products aid in managing common eye-related issues. Lumify, for instance, is a popular eye drop designed to reduce redness.

- Contact Lenses: The company offers an extensive array of contact lenses through its sophisticated brand, Soflens. These lenses provide comfort and clarity for a variety of vision correction needs.

- Lens Care Products: Bausch Health also markets lens care solutions, such as Biotrue Solutions, which are designed to maintain eye health and lens hygiene.

- Ophthalmic Surgical Devices: The company provides advanced surgical devices for eye surgery, contributing to improved surgical outcomes and patient safety.

Dermatology
In the dermatology segment, Bausch Health focuses on developing and marketing prescription products and consumer brands that address various skin conditions. Their portfolio includes:

- Prescription Medicines: Products such as Retin-A Micro, which is used to treat acne and reduce the appearance of fine lines, are central to their offerings.

- Acne Treatments: Bausch Healths AcneFree line provides a range of topical solutions to meet the needs of acne sufferers, offering formulas that are effective yet gentle on the skin.

- Skincare Products: Carpe is another brand under Bausch Health that specializes in sweat-absorbing products, enhancing comfort and confidence for consumers.

Gastrointestinal
Bausch Health’s gastrointestinal segment delivers essential therapies for managing a range of GI disorders. This segment features:

- Prescription Medications: Bausch Healths GI product lineup includes Xifaxan, Apriso, and Colazal, which are designed to treat conditions such as Crohns disease, ulcerative colitis, and irritable bowel syndrome. These medications focus on reducing inflammation and managing symptoms effectively.

- Specialty Products: Within this division, the company emphasizes its commitment to innovation in GI health, delivering therapies that improve patient outcomes and quality of life.

Consumer Health
The Consumer Health segment encompasses a variety of non-prescription products aimed at general wellness and specific health concerns. Key offerings include:

- Dietary Supplements: Bausch Health provides supplements that support overall health and wellness, catering to a range of consumer needs.

- Weight Loss Products: These products are designed to assist individuals in managing their weight effectively.

- Foot Care Products: The companys line of foot care solutions promotes comfort and addresses various foot-related issues.

- Popular Brands: Notable products such as BioTrue Contact Lens Solution and OXY Skincare are widely recognized, with BioTrue supporting contact lens wearers and OXY targeting acne treatment.

Salix Pharmaceuticals
Salix, a division of Bausch Health, is dedicated to developing innovative therapeutic options for gastrointestinal diseases. Key aspects include:

- Leader in GI Medicine: Salix is recognized for its extensive understanding and expertise in gastroenterology, focusing on advanced treatments for conditions like ulcerative colitis and Crohns disease.

- Therapeutic Products: The division offers a robust portfolio of proven therapies that effectively target various GI conditions. Each product is designed to enhance patient quality of life through targeted action and effective symptom management.

Summary
Bausch Health Companies Inc operates within a diverse array of healthcare sectors, emphasizing eye health, dermatology, gastrointestinal care, consumer health, and specialized therapies through Salix. The company is committed to enhancing patient care and outcomes through innovative products and dedicated research, making it a trusted name in both prescription and consumer healthcare markets. The products are designed to address specific health concerns and have earned the trust of healthcare professionals and patients globally.